Decreased Expression of the p16/MTS1 Gene without Mutation is Frequent in Human Urinary Bladder Carcinomas

Japanese Journal of Clinical Oncology

Volumn 27, Issue 1, 1997, Pages 22-25

  Asamoto, Makoto ^a,c   Iwahori, Yoshio ^a   Okamura, Takehiko ^b   Shirai, Tomoyuki ^b   Tsuda, Hiroyuki ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c National Cancer Center   (Japan)

Author keywords

Gene expression; Human urinary bladder carcinomas; P16; Point mutation

Indexed keywords

CARRIER PROTEIN; MESSENGER RNA; PRIMER DNA; PROTEIN P16INK4A;

ARTICLE; BLADDER TUMOR; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; MUTATION; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

CARRIER PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA PRIMERS; GENE EXPRESSION; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RNA, MESSENGER; URINARY BLADDER NEOPLASMS;

EID: 0031067521     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/27.1.22     Document Type: Article

References (27)

1. Knowles MA, Elder PA, Williamson M, Cairns JP, Shaw ME, Law MG. Allelotype of human bladder cancer. Cancer Res 1994;54:531-8.
2. Orlow I, Lianes P, Lacombe L, Dalbagni G, Reuter VE, Cordon CC. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res, 1994;54:2848-51.
3. Cairns P, Shaw ME, Knowles MA. Preliminary mapping of the deleted region of chromosome 9 in bladder cancer. Cancer Res 1993;53:1230-1232.
4. Miyao N, Tsai YC, Lerner SP, Olumi AF, Spruck C3, Gonzalez ZM et al. Role of chromosome 9 in human bladder cancer. Cancer Res 1993;53:4066-70.
5. Cairns P, Tokino K, Eby Y, Sidransky D. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res 1994;54:1422-4.
6. Spruck C3, Ohneseit PF, Gonzalez ZM, Esrig D, Miyao N, Tsai YC et al. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 1994;54:784-8.
7. Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B. Clonal origin of bladder cancer N Eng J Med 1992;326:737-40.
8. Kamb A, Gruis NA, Weaver FJ, Liu Q, Harshman K, Tavtigian SV et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994;264:436-40.
9. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994;368:753-6.
10. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-7.
11. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD et al. Germline p16 mutations in familial melanoma. Nat Genet 1994;8:15-21.
12. Kamb A, Shattuck ED, Eeles R, Liu Q, Gruis NA, Ding W et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 1994;8:23-6.
13. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y. Frequent somatic mutation of the MTS1/CDK41 (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 1994;54:3396-7.
14. Caldas C, Hahn SA, da CL, Redston MS, Schutte M, Seymour AB et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 1994;8:27-32.
15. Hayashi N, Sugimoto Y, Tsuchiya E, Ogawa M, Nakamura Y. Somatic mutations of the MTS (multiple tumor suppressor) 1/CDK41 (cyclin-dependent kinase-4 inhibitor) gene in human primary non-small cell lung carcinomas. Biochem Biophys Res Com 1994;202:1426-30.
16. Spruck C, Gonzalez ZM, Shibata A, Simoneau AR, Lin MF, Gonzales F et al. p16 gene in uncultured tumours. Nature 1994;370:183-4.
17. Cairns P, Mao I., Merlo A, Lee DJ, Schwab D, Eby Y et al. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 1994;265:415-7.
18. Kai M, Arakawa H, Sugimoto Y, Murata Y, Ogawa M, Nakamura Y. Infrequent somatic mutation of the MTS1 gene in primary bladder carcinomas. Jpn J Cancer Res 1995;86:249-51.
19. Orlow I, Lacombe L, Hannon GJ, Serrano M, Pellicer I, Dalbagni G et al. Deletion of the p16 and p15 genes in human bladder tumors. J Nat Cancer Inst 1995;87:1524-9.
20. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet 1995;11:210-2.
21. Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S et al. Deletion of p16 and p15 genes in brain tumors. Cancer Res 1994;54:6353-8
22. Shapiro GI, Edwards CD, Kobzik L, Godleski J, Richards W, Sugarbaker DJ et al. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res 1995;55:505-9.
23. Tam SW, Shay JW, Pagano M, Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4. Cancel Res 1994;54:5816-20.
24. Geradis J, Kratzke RA, Niehans GA, Lincoln CE. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. Cancer Res 1995;55:6006-11
25. Merlo A, Herman JG, Mao L, Lee DJ, Gabnelson E, Burger PC et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Medicine 1995;1:686-92.
26. Sun Y, Hildesheim A, Lanier AE, Cao Y, Yao KT, Raab-Traub N et al. No point mutation but decreased expression of the p16/MTS1 tumor suppressor gene in nasopharyngeal carcinomas. Oncogens 1995;10:785-8.
27. INK4 expression is frequent in high grade glioma. Cancer Res 1995;55:1941-5.